Arcus Development Group Stock
€0.010
Your prediction
Financial data and news for Arcus
sharewise wants to provide you with the best news and tools for Arcus, so we directly link to the best financial data sources.
Financials
News
Summit Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Summit Therapeutics PLC? Here are five stocks we like better.
- Updated HARMONi trial data showed a median follow-up improvement and an overall survival hazard ratio of
An Arcus Insider Sold 68,569 Shares but Kept 1.2 Million After a 200% Run
Juan C. Jaen, the president of Arcus Biosciences, Inc. (NYSE:RCUS), reported a sale of 68,569 shares on July 9, 2026 and July 10, 2026, according to an SEC Form 4 filing.
Arcus Biosciences is a
Arcus Capital Scales Back Dream Finders Homes Stake, According to Recent SEC Filing
According to a Securities and Exchange Commission (SEC) filing dated May 6, 2026, Arcus Capital Partners, LLC reduced its stake in Dream Finders Homes (NYSE:DFH) by 398,536 shares during the first


